Ads
-
Related paper
- BIOTECHNOLOGICAL PRODUCTION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR PROTEIN & ITS APPLICATION
- PRODUCTION AND CHARACTERIZATION OF ANTIBODIES TO TISSUE PLASMINOGEN ACTIVATOR: APPLICATION FOR THE PLATELET FLOW CYTOMETRY ASSAY
- Effect of Tissue Plasminogen Activator on Treatment Outcome and Neuronal Degeneration in Acute Ischemic Stroke
- Vector Delivery-Dependant Effect of Human Tissue Plasminogen Activator Signal Peptide on Vaccine Induction of T Cells
- Correlation between Inflammation and Fibrinolysis in Hypertensive Centrally Obese Subjects: A Study on C-Reactive Protein, Plasminogen Activator Inhibitor-1 and Thrombin Activatable Fibrinolysis Inhibitor
- Plasminogen Activator Inhibitor Type 2 in Human Tears and Blood during Pregnancy
- Production And Characterization Of Recombinant Superoxide Dismutase Protein Expressed In E.Coli
- Recurrent branch retinal arterial occlusions associated with plasminogen activator inhibitor-1 mutation
- Biologically Active Dairy Protein Hydrolysates and Their Cyclodextrin Inclusion Complexes: Biotechnological Aspects of Production
- Expression and Purification of the Recombinant OmpL1 Protein for Potential Vaccine Production against Leptospirosis